Diagnostic chest x-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 9, 2013, Pages 1547-1556

  John, Esther M ^a,b   McGuire, Valerie ^b   Thomas, Duncan ^d   Haile, Robert ^c   Ozcelik, Hilmi ^b,e   Milne, Roger L ^h,i   Felberg, Anna ^b   West, Dee W ^b   Miron, Alexander ^m   Knight, Julia A ^f,g   Terry, Mary Beth ^n,o   Daly, Mary ^p   Buys, Saundra S ^q   Andrulis, Irene L ^b,e   Hopper, John L ⁱ   Southey, Melissa C ^j   Giles, Graham G ^i,k   Apicella, Carmel ⁱ   Thorne, Heather ^l   Whittemore, Alice S ^b  

^a CANCER PREVENTION INSTITUTE OF CALIFORNIA   (United States)

^b Department of Health Research and Policy ^*  (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e Fred A Litwin Centre for Cancer Genetics   (United States)

^f MOUNT SINAI HOSPITAL   (United States)

^g UNIVERSITY OF TORONTO   (Canada)

^h Structural Biology and Biocomputing Programme   (Spain)

ⁱ Genetic and Analytic Epidemiology   (Spain)

^j UNIVERSITY OF MELBOURNE   (Australia)

^k CANCER EPIDEMIOLOGY CENTRE   (Australia)

^l PETER MACCALLUM CANCER CENTRE   (Australia)

^m DANA FARBER CANCER INSTITUTE   (United States)

ⁿ Department of Medicine   (United States)

^o Department of Medicine   (United States)

^p FOX CHASE CANCER CENTER   (United States)

^q UNIVERSITY OF UTAH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; FEMALE; FLUOROSCOPY; GENE MUTATION; HETEROZYGOTE; HUMAN; IONIZING RADIATION; LOW ENERGY RADIATION; MAJOR CLINICAL STUDY; PNEUMONIA; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIODIAGNOSIS; THORAX RADIOGRAPHY; TUBERCULOSIS;

ADULT; AUSTRALIA; BREAST NEOPLASMS; CANADA; DIAGNOSTIC TESTS, ROUTINE; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MUTATION; NEW ZEALAND; RADIOGRAPHY, THORACIC; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 84884150134     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0189     Document Type: Article

References (39)

1. Ronckers CM, Erdmann CA, Land CE. Radiation and breast cancer: a review of current evidence. Breast Cancer Res 2005;7: 21-32.
2. Preston DL, Mattsson A, Holmberg E, Shore R, Hildreth NG, Boice JD Jr. Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat Res 2002;158: 220-35.
3. Boice JD Jr, Preston D, Davis FG, Monson RR. Frequent chest X-ray fluoroscopy and breast cancer incidence among tuberculosis patients in Massachusetts. Radiat Res 1991;125: 214-22.
4. Howe GR, McLaughlin J. Breast cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with breast cancer mortality in the atomic bomb survivors study. Radiat Res 1996;145: 694-707.
5. Ronckers CM, Doody MM, Lonstein JE, Stovall M, Land CE. Multiple diagnostic X-rays for spine deformities and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2008;17: 605-13.
6. Hill DA, Preston-Martin S, Ross RK, Bernstein L. Medical radiation, family history of cancer, and benign breast disease in relation to breast cancer risk in young women, USA. Cancer Causes Control 2002; 13: 711-8.
7. Ma H, Hill CK, Bernstein L, Ursin G. Low-dose medical radiation exposure and breast cancer risk in women under age 50 years overall and by estrogen and progesterone receptor status: results from a case-control and a case-case comparison. Breast Cancer Res Treat 2008;109: 77-90.
8. John EM, Phipps AI, Knight JA, Milne RL, Dite GS, Hopper JL, et al. Medical radiation exposure and breast cancer risk: findings from the Breast Cancer Family Registry. Int J Cancer 2007;121: 386-94.
9. Andrieu N, Easton DF, Chang-Claude J, Rookus MA, Brohet R, Cardis E, et al. Effect of chest X-rays on the risk of breast cancer among BRCA1/2 mutation carriers in the international BRCA1/2 carrier cohort study: a report from the EMBRACE, GENEPSO, GEO-HEBON, and IBCCS Collaborators' Group. J Clin Oncol 2006;24: 3361-6.
10. Gronwald J, Pijpe A, Byrski T, Huzarski T, Stawicka M, Cybulski C, et al. Early radiation exposures and BRCA1-associated breast cancer in young women from Poland. Breast Cancer Res Treat 2008;112: 581-4.
11. Lecarpentier J, Nogues C, Mouret-Fourme E, Stoppa-Lyonnet D, Lasset C, Caron O, et al. Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French NationalBRCA1/2 carrier cohort (GENEPSO). Breast Cancer Res Treat 2011;130: 927-38.
12. Pijpe A, Andrieu N, Easton DF, Kesminiene A, Cardis E, Nogues C, et al. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENERAD- RISK). BMJ 2012;345:e5660.
13. Narod SA, Lubinski J, Ghadirian P, Lynch HT, Moller P, Foulkes WD, et al. Screening mammography and risk of breast cancer inBRCA1 and BRCA2 mutation carriers: a case-control study. Lancet Oncol 2006;7: 402-6.
14. Goldfrank D, Chuai S, Bernstein JL, Ramon YCT, Lee JB, Alonso MC, et al. Effect of mammography on breast cancer risk in women with mutations in BRCA1 or BRCA2. Cancer Epidemiol Biomarkers Prev 2006;15: 2311-3.
15. Powell SN, Kachnic LA. Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation. Oncogene 2003;22: 5784-91.
16. Boice JD Jr, Harvey EB, Blettner M, Stovall M, Flannery JT. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 1992;326: 781-5.
17. Broeks A, Braaf LM, Huseinovic A, Nooijen A, Urbanus J, Hogervorst FB, et al. Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study. Breast Cancer Res 2007;9:R26.
18. Mellemkjaer L, Dahl C, Olsen JH, Bertelsen L, Guldberg P, Christensen J, et al. Risk for contralateral breast cancer among carriers of the CHEK2-1100delC mutation in the WECARE Study. Br J Cancer 2008;98: 728-33.
19. Bernstein JL, Haile RW, Stovall M, Boice JD Jr, Shore RE, Langholz B, et al. Radiation exposure, the ATM Gene, and contralateral breast cancer in the women's environmental cancer and radiation epidemiology study. J Natl Cancer Inst 2010;102: 475-83.
20. Haile RW, Thomas DC, McGuire V, Felberg A, John EM, Milne RL, et al. BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Cancer Epidemiol Biomarkers Prev 2006; 15: 1863-70.
21. John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, et al. The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res 2004;6: R375-89.
22. Osborne RH, Hopper JL, Kirk JA, Chenevix-Trench G, Thorne HJ, Sambrook JF. kConFab: a research resource of Australasian breast cancer families. Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer. Med J Aust 2000;172: 463-4.
23. Andrulis IL, Anton-Culver H, Beck J, Bove B, Boyd J, Buys S, et al. Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations. Hum Mutat 2002;20: 65-73.
24. Neuhausen SL, Ozcelik H, Southey MC, John EM, Godwin AK, Chung W, et al. BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research. Breast Cancer Res Treat 2009;116: 379-86.
25. Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E, et al. Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 2006; 8:R12.
26. Whittemore AS, Halpern J. Multi-stage sampling in genetic epidemiology. Stat Med 1997;16: 153-67.
27. Morin Doody M, Lonstein JE, Stovall M, Hacker DG, Luckyanov N, Land CE. Breast cancer mortality after diagnostic radiography: findings from the U.S. Scoliosis Cohort Study. Spine 2000;25: 2052-63.
28. Regulla DF, Eder H. Patient exposure in medical X-ray imaging in Europe. Radiat Prot Dosimetry 2005;114: 11-25.
29. Berrington de Gonzalez A, Ekbom A, Glass AG, Galanti MR, Grimelius L, Allison MJ, et al. Comparison of documented and recalled histories of exposure to diagnostic x-rays in case-control studies of thyroid cancer. Am J Epidemiol 2003;157: 652-63.
30. John EM, Miron A, Gong G, Phipps AI, Felberg A, Li FP, et al. Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 2007;298: 2869-76.
31. Kurian AW. BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications. Curr Opin Obstet Gynecol 2010; 22: 72-8.
32. Thompson D, Easton D. Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 2001;68: 410-9.
33. Thompson D, Easton D. Variation in BRCA1 cancer risks by mutation position. Cancer Epidemiol Biomarkers Prev 2002;11: 329-36.
34. Pogoda JM, Preston-Martin S. Radiation exposure from diagnostic imaging: agreement between self-report and medical records. Health Phys 2002;83: 907-17.
35. Hallquist A, Jansson P. Self-reported diagnostic X-ray investigation and data from medical records in case-control studies on thyroid cancer: evidence of recall bias? Eur J Cancer Prev 2005;14: 271-6.
36. Pijpe A, Manders P, Mulder RL, van Leeuwen FE, Rookus MA. Reliability of self-reported diagnostic radiation history in BRCA1/2 mutation carriers. Eur J Epidemiol 2010;25: 103-13.
37. Brenner DJ, Hall EJ. Computed tomography-an increasing source of radiation exposure. N Engl J Med 2007;357: 2277-84.
38. Pearce MS. Patterns in paediatric CT use: an international and epidemiological perspective. J Med Imaging Radiat Oncol 2011;55: 107-9.
39. Smith-Bindman R. Environmental causes of breast cancer and radiation from medical imaging: findings from the Institute of Medicine report. Arch Intern Med 2012;172: 1023-7.